40 results

• Valsartan Bellwether Lawsuit Over Cancer Caused by Recalled Blood Pressure Drug Set for Trial September 8, 2025

  December 4, 2024

  Irvin Jackson

  The first Valsartan bellwether trial will begin on September 8, 2025, involving allegations that the generic hypertension drug contained toxic chemicals that resulted in a liver cancer diagnosis.

• Valsartan Liver Cancer Lawsuit Selected for First Jury Trial in MDL

  October 28, 2024

  Irvin Jackson

  The first bellwether trial in the federal Valsartan MDL will involve claims brought by an Alabama man diagnosed with liver cancer, which is the injury most commonly reported among former users of the recalled blood pressure drug.

• Valsartan Cancer Lawsuits To Be Set for First Bellwether Trial, Instead of Third-Party Payor Claim

  October 22, 2024

  Irvin Jackson

  Following the postponement of a third party payor trial previously set to begin this month, the judge presiding over all valsartan lawsuits will hold a conference today with lawyers to discuss the selection of a cancer claim that will now be the first to go before a jury.

• Sanctions Imposed in Valsartan Recall Lawsuits Over Drug Maker’s Discovery Violations

  July 25, 2024

  Irvin Jackson

  A Chinese generic valsartan manufacturer has been fined more than 300,000 for failing to adhere to discovery requirements and make its CEO available for depositions.

• More Than 1,200 Valsartan Lawsuits Pending in MDL Over Cancers Caused By Recalled Blood Pressure Drug

  July 15, 2024

  Irvin Jackson

  Plaintiffs and defendants have briefed the new incoming judge on the status of more than 1,200 Valsartan lawsuits ahead of a meeting later this month, which seeks to begin moving the litigation forward following the retirement of the preceding presiding judge.

• Valsartan Settlements Reached To Resolve Personal Injury, Class Action and Medical Monitoring Claims Against Hetero

  June 4, 2024

  Irvin Jackson

  A preliminary Valsartan settlement agreement has been announced that would resolve all personal injury, economic loss and medical monitoring lawsuits against Hetero, Inc., a drug manufacturer from India.

• Valsartan Injury Lawyers To Meet With U.S. District Judge Recently Appointed To Preside Over Litigation

  May 23, 2024

  Irvin Jackson

  A new judge has been assigned to oversee Valsartan recall lawsuits consolidated in federal court, and plaintiffs wish to meet with her regarding the status of the litigation and several potential settlement agreements.

• Extended Use of Valsartan and Other Angiotensin-Receptor Blockers May Increase Cancer Risk: Study

  March 4, 2022

  Russell Maas

  Valsartan and similar hypertension drugs may carry an increased risk of cancer with long-term use, according to the findings of a new study.

• Lupin Irebesartan Recall Issued Over Cancer Causing N-nitrosoirbesartan Contamination

  October 15, 2021

  Irvin Jackson

  Nearly 80 lots of Irbesartan and Irbesartan/HCTZ combination tablets are being recalled due to the presence of a potentially cancer-causing chemical.

• New Irbesartan Recalls Announced Abroad Raising Concerns About New “Sartan” Contaminant: Azido

  August 11, 2021

  Irvin Jackson

  A growing number of international recalls of irbesartan products is raising concerns about a potentially cancer-causing mutagen called azido, which may result in another global hypertension drug recall similar to the one caused by NDMA contamination.